John Snisarenko

John Snisarenko is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as an Independent Director and Board Member at Cytophage Technologies Ltd., Triera Biosciences, and Zentek Ltd., Snisarenko also chairs the Commercialization Committee and is a member of the Audit and Compensation Committees. With a strong background in commercial strategy and leadership, Snisarenko has held key positions such as Chief Commercial Officer at Oyster Point Pharma and Group Vice President at Takeda, as well as significant roles at Genentech and NOVADAQ. An alumnus of McGill University, Snisarenko possesses an MBA in Marketing and International Business and a BSc in Biochemistry.